Astellas and Dyno Therapeutics announced a research collaboration to develop next-generation adeno-associated virus (AAV) gene therapy vectors for skeletal and cardiac muscle using Dyno’s CapsidMap platform.
If you are not happy with the results below please do another search
50 search results for:
Novavax Inc. said on Thursday the company could begin commercial manufacturing of a Covid-19 vaccine tailored for the Omicron coronavirus variant in January 2022, while testing whether or not its current vaccine works against the variant.
A case of the Omicron coronavirus variant was identified in Minnesota on December 2, the U.S. state’s health department said, with the identification coming a day after the United States reported the country’s first case of the new variant.
Amgen’s oral drug candidate for genital psoriasis delivered positive topline results from a Phase III trial, with both primary and secondary endpoints met by Otezla (apremilast).
We are entering a golden age of biomedical diagnostics and personalized treatment. The cost of pharmacogenetic testing continues to decline and more insurers are offering coverage for these tests. This will allow clinicians and medical researchers to really drill down into the data to improve patient outcomes and determine in advance what treatment will work best – and which treatments to avoid – for each individual. It’s an exciting time, according to Jonathan Stein, Chief Scientific Officer at Tesis Biosciences.
Laboratory analysis of the antibody-based Covid-19 therapy GlaxoSmithKline is developing with U.S. partner Vir Biotechnology indicated the drug is effective against the new Omicron variant, the British drugmaker said on December 2.
The Ashfield Health mantra is make it matter. According to management, this is more than a phrase—it’s a powerful purpose. On November 12th, Ashfield Health set out to make a difference as 1,500 people from 7 agencies, across 7 countries came together to make a positive impact on their communities.
Fears over the impact of the Omicron variant of the coronavirus rose on Thursday after the first case was reported in the United States and the Japanese central bank warned of economic pain as countries respond with tighter containment measures.
Bristol Myers Squibb Co. was sued on December 1 by four employees who said the drugmaker refused to grant them religious exemptions from the company’s Covid-19 vaccination requirement, and threatened to fire them on Dec. 6 for remaining unvaccinated.
U.S. President Joe Biden on December 1 unveiled an updated national strategy to combat the AIDS epidemic by boosting money for research, increasing access to treatment, and recognizing the role racism plays in inequitable access to medical services.